nodes	percent_of_prediction	percent_of_DWPC	metapath
Penbutolol—Respiratory distress—Fludarabine—lymphatic system cancer	0.0561	0.0561	CcSEcCtD
Penbutolol—Arterial thrombosis—Methotrexate—lymphatic system cancer	0.0392	0.0392	CcSEcCtD
Penbutolol—Respiratory distress—Vincristine—lymphatic system cancer	0.0343	0.0343	CcSEcCtD
Penbutolol—Depression—Mechlorethamine—lymphatic system cancer	0.0307	0.0307	CcSEcCtD
Penbutolol—Agranulocytosis—Mechlorethamine—lymphatic system cancer	0.0287	0.0287	CcSEcCtD
Penbutolol—Alopecia—Mechlorethamine—lymphatic system cancer	0.0244	0.0244	CcSEcCtD
Penbutolol—Sweating—Teniposide—lymphatic system cancer	0.0217	0.0217	CcSEcCtD
Penbutolol—Disorientation—Bleomycin—lymphatic system cancer	0.0212	0.0212	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Fludarabine—lymphatic system cancer	0.0208	0.0208	CcSEcCtD
Penbutolol—Alopecia—Teniposide—lymphatic system cancer	0.018	0.018	CcSEcCtD
Penbutolol—Amnesia—Carmustine—lymphatic system cancer	0.0176	0.0176	CcSEcCtD
Penbutolol—Alopecia—Fludarabine—lymphatic system cancer	0.0158	0.0158	CcSEcCtD
Penbutolol—Hyperhidrosis—Teniposide—lymphatic system cancer	0.014	0.014	CcSEcCtD
Penbutolol—Cough—Fludarabine—lymphatic system cancer	0.0136	0.0136	CcSEcCtD
Penbutolol—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.0134	0.0134	CcSEcCtD
Penbutolol—Dyspnoea—Teniposide—lymphatic system cancer	0.0129	0.0129	CcSEcCtD
Penbutolol—Depression—Carmustine—lymphatic system cancer	0.0127	0.0127	CcSEcCtD
Penbutolol—Erectile dysfunction—Vincristine—lymphatic system cancer	0.0126	0.0126	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Mitoxantrone—lymphatic system cancer	0.0124	0.0124	CcSEcCtD
Penbutolol—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.0123	0.0123	CcSEcCtD
Penbutolol—Erectile dysfunction—Mitoxantrone—lymphatic system cancer	0.0123	0.0123	CcSEcCtD
Penbutolol—Depression—Vincristine—lymphatic system cancer	0.0121	0.0121	CcSEcCtD
Penbutolol—Sweating—Vincristine—lymphatic system cancer	0.0117	0.0117	CcSEcCtD
Penbutolol—Nausea—Mechlorethamine—lymphatic system cancer	0.0117	0.0117	CcSEcCtD
Penbutolol—Alopecia—Bleomycin—lymphatic system cancer	0.0116	0.0116	CcSEcCtD
Penbutolol—Body temperature increased—Teniposide—lymphatic system cancer	0.0114	0.0114	CcSEcCtD
Penbutolol—Sweating—Mitoxantrone—lymphatic system cancer	0.0114	0.0114	CcSEcCtD
Penbutolol—Dyspnoea—Fludarabine—lymphatic system cancer	0.0113	0.0113	CcSEcCtD
Penbutolol—Dyspepsia—Fludarabine—lymphatic system cancer	0.0112	0.0112	CcSEcCtD
Penbutolol—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.0111	0.0111	CcSEcCtD
Penbutolol—Fatigue—Fludarabine—lymphatic system cancer	0.011	0.011	CcSEcCtD
Penbutolol—Pain—Fludarabine—lymphatic system cancer	0.0109	0.0109	CcSEcCtD
Penbutolol—Bradycardia—Mitoxantrone—lymphatic system cancer	0.0108	0.0108	CcSEcCtD
Penbutolol—Asthenia—Teniposide—lymphatic system cancer	0.0104	0.0104	CcSEcCtD
Penbutolol—Alopecia—Carmustine—lymphatic system cancer	0.0101	0.0101	CcSEcCtD
Penbutolol—Body temperature increased—Fludarabine—lymphatic system cancer	0.0101	0.0101	CcSEcCtD
Penbutolol—Cough—Bleomycin—lymphatic system cancer	0.00997	0.00997	CcSEcCtD
Penbutolol—Diarrhoea—Teniposide—lymphatic system cancer	0.0099	0.0099	CcSEcCtD
Penbutolol—Alopecia—Vincristine—lymphatic system cancer	0.00966	0.00966	CcSEcCtD
Penbutolol—Alopecia—Mitoxantrone—lymphatic system cancer	0.00941	0.00941	CcSEcCtD
Penbutolol—Asthenia—Fludarabine—lymphatic system cancer	0.00912	0.00912	CcSEcCtD
Penbutolol—Headache—Teniposide—lymphatic system cancer	0.00906	0.00906	CcSEcCtD
Penbutolol—Diarrhoea—Fludarabine—lymphatic system cancer	0.0087	0.0087	CcSEcCtD
Penbutolol—Nausea—Teniposide—lymphatic system cancer	0.00859	0.00859	CcSEcCtD
Penbutolol—Dyspnoea—Bleomycin—lymphatic system cancer	0.00831	0.00831	CcSEcCtD
Penbutolol—Cough—Mitoxantrone—lymphatic system cancer	0.00809	0.00809	CcSEcCtD
Penbutolol—Pain—Bleomycin—lymphatic system cancer	0.00797	0.00797	CcSEcCtD
Penbutolol—Headache—Fludarabine—lymphatic system cancer	0.00797	0.00797	CcSEcCtD
Penbutolol—Nausea—Fludarabine—lymphatic system cancer	0.00755	0.00755	CcSEcCtD
Penbutolol—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00751	0.00751	CcSEcCtD
Penbutolol—Body temperature increased—Bleomycin—lymphatic system cancer	0.00737	0.00737	CcSEcCtD
Penbutolol—Insomnia—Carmustine—lymphatic system cancer	0.00736	0.00736	CcSEcCtD
Penbutolol—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00731	0.00731	CcSEcCtD
Penbutolol—Mood swings—Methotrexate—lymphatic system cancer	0.00727	0.00727	CcSEcCtD
Penbutolol—Dyspnoea—Carmustine—lymphatic system cancer	0.00726	0.00726	CcSEcCtD
Penbutolol—Insomnia—Vincristine—lymphatic system cancer	0.00703	0.00703	CcSEcCtD
Penbutolol—Pain—Carmustine—lymphatic system cancer	0.00696	0.00696	CcSEcCtD
Penbutolol—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00675	0.00675	CcSEcCtD
Penbutolol—Fatigue—Vincristine—lymphatic system cancer	0.0067	0.0067	CcSEcCtD
Penbutolol—Asthenia—Bleomycin—lymphatic system cancer	0.00669	0.00669	CcSEcCtD
Penbutolol—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00666	0.00666	CcSEcCtD
Penbutolol—Pain—Vincristine—lymphatic system cancer	0.00664	0.00664	CcSEcCtD
Penbutolol—Fatigue—Mitoxantrone—lymphatic system cancer	0.00652	0.00652	CcSEcCtD
Penbutolol—Pain—Mitoxantrone—lymphatic system cancer	0.00647	0.00647	CcSEcCtD
Penbutolol—Body temperature increased—Carmustine—lymphatic system cancer	0.00643	0.00643	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.00616	0.00616	CcSEcCtD
Penbutolol—Body temperature increased—Vincristine—lymphatic system cancer	0.00614	0.00614	CcSEcCtD
Penbutolol—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.0061	0.0061	CcSEcCtD
Penbutolol—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00598	0.00598	CcSEcCtD
Penbutolol—Depression—Methotrexate—lymphatic system cancer	0.00589	0.00589	CcSEcCtD
Penbutolol—Asthenia—Carmustine—lymphatic system cancer	0.00584	0.00584	CcSEcCtD
Penbutolol—Sweating—Methotrexate—lymphatic system cancer	0.00567	0.00567	CcSEcCtD
Penbutolol—Asthenia—Vincristine—lymphatic system cancer	0.00557	0.00557	CcSEcCtD
Penbutolol—Diarrhoea—Carmustine—lymphatic system cancer	0.00557	0.00557	CcSEcCtD
Penbutolol—Nausea—Bleomycin—lymphatic system cancer	0.00554	0.00554	CcSEcCtD
Penbutolol—Agranulocytosis—Methotrexate—lymphatic system cancer	0.00552	0.00552	CcSEcCtD
Penbutolol—Asthenia—Mitoxantrone—lymphatic system cancer	0.00543	0.00543	CcSEcCtD
Penbutolol—Dizziness—Carmustine—lymphatic system cancer	0.00538	0.00538	CcSEcCtD
Penbutolol—Diarrhoea—Vincristine—lymphatic system cancer	0.00532	0.00532	CcSEcCtD
Penbutolol—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00518	0.00518	CcSEcCtD
Penbutolol—Dizziness—Vincristine—lymphatic system cancer	0.00514	0.00514	CcSEcCtD
Penbutolol—Headache—Carmustine—lymphatic system cancer	0.0051	0.0051	CcSEcCtD
Penbutolol—Headache—Vincristine—lymphatic system cancer	0.00487	0.00487	CcSEcCtD
Penbutolol—Nausea—Carmustine—lymphatic system cancer	0.00483	0.00483	CcSEcCtD
Penbutolol—Headache—Mitoxantrone—lymphatic system cancer	0.00474	0.00474	CcSEcCtD
Penbutolol—Alopecia—Methotrexate—lymphatic system cancer	0.00469	0.00469	CcSEcCtD
Penbutolol—Nausea—Vincristine—lymphatic system cancer	0.00461	0.00461	CcSEcCtD
Penbutolol—Nausea—Mitoxantrone—lymphatic system cancer	0.00449	0.00449	CcSEcCtD
Penbutolol—Cough—Methotrexate—lymphatic system cancer	0.00403	0.00403	CcSEcCtD
Penbutolol—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.00364	0.00364	CcSEcCtD
Penbutolol—Insomnia—Methotrexate—lymphatic system cancer	0.00341	0.00341	CcSEcCtD
Penbutolol—Dyspnoea—Methotrexate—lymphatic system cancer	0.00336	0.00336	CcSEcCtD
Penbutolol—Dyspepsia—Methotrexate—lymphatic system cancer	0.00332	0.00332	CcSEcCtD
Penbutolol—Fatigue—Methotrexate—lymphatic system cancer	0.00325	0.00325	CcSEcCtD
Penbutolol—Pain—Methotrexate—lymphatic system cancer	0.00322	0.00322	CcSEcCtD
Penbutolol—Body temperature increased—Methotrexate—lymphatic system cancer	0.00298	0.00298	CcSEcCtD
Penbutolol—Asthenia—Methotrexate—lymphatic system cancer	0.0027	0.0027	CcSEcCtD
Penbutolol—Diarrhoea—Methotrexate—lymphatic system cancer	0.00258	0.00258	CcSEcCtD
Penbutolol—Dizziness—Methotrexate—lymphatic system cancer	0.00249	0.00249	CcSEcCtD
Penbutolol—Headache—Methotrexate—lymphatic system cancer	0.00236	0.00236	CcSEcCtD
Penbutolol—Nausea—Methotrexate—lymphatic system cancer	0.00224	0.00224	CcSEcCtD
